Screener
Beta Bionics BBNX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Sales and marketing | 24,640 | 15,623 | 45,375 | 29,025 |
| General and administrative | 9,600 | 7,879 | 19,217 | 14,500 |
| Total operating expenses | 44,480 | 32,375 | 85,188 | 59,988 |
| Loss from operations | (25,578) | (19,872) | (49,849) | (38,514) |
| Other income (expense): | ||||
| Interest income | 2,177 | 3,005 | 4,553 | 5,441 |
| Other expense | (2) | (2) | (2) | (2) |
| Change in fair value of warrant liabilities | — | — | — | (12,450) |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's operating income?
- Beta Bionics (BBNX) reported operating income of -$25.58M in Q2 2026.
- How has Beta Bionics's operating income changed year-over-year?
- Beta Bionics's operating income decreased by 28.7% year-over-year, from -$19.87M to -$25.58M.
- What is the long-term trend for Beta Bionics's operating income?
- Over 2 years (2023 to 2025), Beta Bionics's operating income has grown at a 41.4% compound annual growth rate (CAGR), from -$35.85M to -$71.68M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Beta Bionics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude